HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high

$0.43

Daily low

$0.41

Price at open

$0.42

52 Week High

$2.30

52 Week Low

$0.38

Market cap

81.1M

Dividend yield

0.00%

Volume

100,727

Avg. volume

4.9M

P/E ratio

-2.43

Heron Therapeutics News